Member State EU/EEA Marketing Authorisation Holder (Invented) name Strength Pharmaceutical Form Route of administration Content (concentration)

Austria AstraZeneca Österreich GmbH, Schwarzenbergplatz 7 A-1037 Wien Austria Optinem i.v. 500 mg - Trockenstechampullen 500 mg Powder for solution for injection or infusion Intravenous use 500 mg/20ml

Austria AstraZeneca Österreich GmbH, Schwarzenbergplatz 7 A-1037 Wien Austria Optinem i.v. 1 g - Trockenstechampullen 1 g Powder for solution for injection or infusion Intravenous use 1 g /30 ml

Belgium NV AstraZeneca SA Rue Egide Van Ophemstraat 110 1180 Brussel Belgium Meronem IV 500 mg 500 mg Powder for solution for injection or infusion Intravenous use 500 mg/20 ml

Belgium NV AstraZeneca SA Rue Egide Van Ophemstraat 110 1180 Brussel Belgium Meronem IV 1 g 1 g Powder for solution for injection or infusion Intravenous use 1 g/30 ml

Bulgaria AstraZeneca UK Limited 600 Capability Green Luton LU1 3LU United Kingdom Meronem 500 mg Powder for solution for injection or infusion Intravenous use 500 mg/20 ml

Bulgaria AstraZeneca UK Limited 600 Capability Green Luton LU1 3LU United Kingdom Meronem 1 g Powder for solution for injection or infusion Intravenous use 1 g/30 ml

Cyprus AstraZeneca UK Ltd. Silk Road Business Park 1 Macclesfield Cheshire SK10 2NA United Kingdom Meronem 500 mg Powder for solution for injection or infusion Intravenous use 500 mg/20 ml

Cyprus AstraZeneca UK Ltd. Silk Road Business Park 1 Macclesfield Cheshire SK10 2NA United Kingdom Meronem 1 g Powder for solution for injection or infusion Intravenous use 1 g/30 ml

Czech Republic AstraZeneca UK Ltd. Silk Road Business Park 1 Macclesfield Cheshire SK10 2NA United Kingdom Meronem 500 mg Powder for solution for injection Intravenous use 500 mg/20 ml

Czech Republic AstraZeneca UK Ltd. Silk Road Business Park 1 Macclesfield Cheshire SK10 2NA United Kingdom Meronem 1 g Powder for solution for injection Intravenous use 1 g/30 ml

Denmark AstraZeneca A/S Roskildevej 22 2620 Albertslund Denmark Meronem 500 mg Powder for solution for injection or infusion Intravenous use 500 mg/20 ml

Denmark AstraZeneca A/S Roskildevej 22 2620 Albertslund Denmark Meronem 1 g Powder for solution for injection or infusion Intravenous use 1 g/30 ml

Estonia AstraZeneca UK Limited 15 Stanhope Gate London W1K 1LN United Kingdom Meronem 500mg Powder for solution for injection or infusion Intravenous use 500 mg/10 ml

Estonia AstraZeneca UK Limited 15 Stanhope Gate London W1K 1LN United Kingdom Meronem 1 g Powder for solution for injection or infusion Intravenous use 1 g/20 ml

Finland AstraZeneca Oy Luomanportti 3 FI-02200 Espoo Finland Meronem 500 mg 500 mg Powder for solution for injection or infusion Intravenous use 500 mg/20 ml

Finland AstraZeneca Oy Luomanportti 3 FI-02200 Espoo Finland Meronem 1 g 1 g Powder for solution for injection or infusion Intravenous use 1 g/30 ml

France AstraZeneca 1, Place Renault 92844 RUEIL-MALMAISON Cédex France Meronem 500 mg poudre pour solution injectable IV 500 mg Powder for solution for injection or infusion Intravenous use 500 mg/20 ml

France AstraZeneca 1, Place Renault 92844 RUEIL-MALMAISON Cédex France Meronem 1 g poudre pour solution injectable IV 1 g Powder for solution for injection or infusion Intravenous use 1 g/30 ml

Germany AstraZeneca GmbH Tinsdaler Weg 183 22880 Wedel Germany Meronem 500 mg 500 mg Powder for solution for injection or infusion Intravenous use 500 mg/10 ml 5 mg / ml

Germany AstraZeneca GmbH Tinsdaler Weg 183 22880 Wedel Germany Meronem 1 000 mg 1 g Powder for solution for injection or infusion Intravenous use 1 g/20 ml 5 mg / ml

Greece ”CANA” SA Pharmaceutical laboratories 446 Irakliou Ave. 14122 Iraklio Attikis Greece Meronem 500 mg Powder for solution for injection or infusion Intravenous use 500 mg/20 ml

Greece ”CANA” SA Pharmaceutical laboratories 446 Irakliou Ave 14122 Iraklio Attikis Greece Meronem 1 g Powder for solution for injection or infusion Intravenous use 1 g/30 ml

Hungary AstraZeneca Kft. H-2045 Törökbálint Park u. 3. Hungary Meronem 500 mg intravenas injekcio 500 mg Powder for solution for injection or infusion Intravenous use 500 mg/20 ml

Hungary AstraZeneca Kft. H-2045 Törökbálint Park u. 3. Hungary Meronem 1 g intravenas injekcio 1 g Powder for solution for injection or infusion Intravenous use 1 g/30 ml

Iceland AstraZeneca UK Ltd. Alderley Park Macclesfield Cheshire SK10 4TG United Kingdom Meronem 500 mg stungulyfs-/innrennslisstofn, lausn. 500 mg Powder for solution for injection or infusion Intravenous use 500 mg/20 ml

Iceland AstraZeneca UK Ltd. Alderley Park Macclesfield Cheshire SK10 4TG United Kingdom Meronem 1 g stungulyfs-/innrennslisstofn, lausn. 1 g Powder for solution for injection or infusion Intravenous use 1 g/30 ml

Ireland AstraZeneca UK Limited 600 Capability Green Luton Bedfordshire LU1 3LU United Kingdom Meronem IV 0.5 g powder for solution for injection or infusion. 0,5 g Powder for solution for injection or infusion. Intravenous use 500 mg/20 ml

Ireland AstraZeneca UK Limited 600 Capability Green Luton Bedfordshire LU1 3LU United Kingdom Meronem IV 1 g powder for solution for injection or infusion. 1 g Powder for solution for injection or infusion. Intravenous use 1 g/30 ml

Italy AstraZeneca S.p.A. Palazzo Volta Via F. Sforza 20080 Basiglio (MI) Italy MERREM 500 mg Powder for solution for injection or infusion Intravenous use 500 mg

Italy AstraZeneca S.p.A. Palazzo Volta Via F. Sforza 20080 Basiglio (MI) Italy MERREM 1 g Powder for solution for injection or infusion Intravenous use 1 g

Italy AstraZeneca S.p.A. Palazzo Volta Via F. Sforza 20080 Basiglio (MI) Italy MERREM 500 mg Powder and solvent for solution for injection Intramuscular use 500 mg/2 ml (not marketed)

Italy AstraZeneca S.p.A. Palazzo Volta Via F. Sforza 20080 Basiglio (MI) Italy MERREM 250 mg Powder and solvent for solution for injection or infusion Intravenous use 250 mg/5 ml (not marketed)

Italy AstraZeneca S.p.A. Palazzo Volta Via F. Sforza 20080 Basiglio (MI) Italy MERREM 500 mg Powder and solvent for solution for injection or infusion Intravenous use 500 mg/10 ml (not marketed)

Italy AstraZeneca S.p.A. Palazzo Volta Via F. Sforza 20080 Basiglio (MI) Italy MERREM 1 g Powder and solvent for solution for injection or infusion Intravenous use 1 g/20 ml (not marketed)

Italy AstraZeneca S.p.A. Palazzo Volta Via F. Sforza 20080 Basiglio (MI) Italy MERREM 250 mg Powder and solvent for solution for infusion Intravenous use 250 mg/100 ml (not marketed)

Italy AstraZeneca S.p.A. Palazzo Volta Via F. Sforza 20080 Basiglio (MI) Italy MERREM 500 mg Powder and solvent for solution for infusion Intravenous use 500 mg/100 ml (not marketed)

Italy AstraZeneca S.p.A. Palazzo Volta Via F. Sforza 20080 Basiglio (MI) Italy MERREM 1 g Powder and solvent for solution for infusion Intravenous use 1 g/100 ml (not marketed)

Latvia AstraZeneca UK Ltd. Silk Road Business Park 1 Macclesfield Cheshire SK10 2NA United Kingdom Meronem 500 mg 500 mg Powder for solution for injection or infusion Intravenous use 500 mg/20 ml

Latvia AstraZeneca UK Ltd. Silk Road Business Park 1 Macclesfield Cheshire SK10 2NA United Kingdom Meronem 1 g 1 g Powder for solution for injection or infusion Intravenous use 1 g/30 ml

Lithuania AstraZeneca UK Ltd. Silk Road Business Park 1 Macclesfield Cheshire SK10 2NA United Kingdom Meronem IV 500 mg Powder for solution for injection or infusion Intravenous use 500 mg/10 ml

Lithuania AstraZeneca UK Ltd. Silk Road Business Park 1 Macclesfield Cheshire SK10 2NA United Kingdom Meronem IV 1 g Powder for solution for injection or infusion Intravenous use 1 g/20 ml

Luxembourg NV AstraZeneca SA Rue Egide Van Ophemstraat 110 1180 Brussel Belgium Meronem IV 500 mg 500 mg Powder for solution for injection or infusion Intravenous use 500 mg/20 ml

Luxembourg NV AstraZeneca SA Rue Egide Van Ophemstraat 110 1180 Brussel Belgium Meronem IV 1 g 1 g Powder for solution for injection or infusion Intravenous use 1 g/30 ml

Malta AstraZeneca UK Ltd. Silk Road Business Park 1 Macclesfield Cheshire SK10 2NA United Kingdom Meronem IV 0,5 g powder for solution for injection or infusion. 0,5 g Powder for solution for injection or infusion Intravenous use 500 mg/20 ml

Malta AstraZeneca UK Ltd. Silk Road Business Park 1 Macclesfield Cheshire SK10 2NA United Kingdom Meronem IV 1 g powder for solution for injection or infusion. 1 g Powder for solution for injection or infusion Intravenous use 1 g/30 ml

Netherlands AstraZeneca BV at the Louis Pasteurlaan 5 2719 EE, Zoetermeer, Netherlands Meronem i.v. 250 mg Powder for solution for injection or infusion Intravenous use In the process of being cancelled

Netherlands AstraZeneca BV at the Louis Pasteurlaan 5 2719 EE, Zoetermeer, Netherlands Meronem i.v. 500 mg Powder for solution for injection or infusion Intravenous use 500 mg/20 ml

Netherlands AstraZeneca BV at the Louis Pasteurlaan 5 2719 EE, Zoetermeer, Netherlands Meronem i.v. 1 g Powder for solution for injection or infusion Intravenous use 1 g/30 ml

Norway AstraZeneca AS Hoffsveien 70 B/Postboks 200 Vinderen 0319 OSLO Norway Meronem 500 mg Powder for solution for injection or infusion Intravenous use 500 mg/20 ml

Norway AstraZeneca AS Hoffsveien 70 B/Postboks 200 Vinderen 0319 OSLO Norway Meronem 1 g Powder for solution for injection or infusion Intravenous use 1 g/30 ml

Poland AstraZeneca UK Ltd. Silk Road Business Park 1 Macclesfield Cheshire SK10 2NA United Kingdom Meronem 500 mg Powder for solution for injection Intravenous use 500 mg/20 ml

Poland AstraZeneca UK Ltd. Silk Road Business Park 1 Macclesfield Cheshire SK10 2NA United Kingdom Meronem 1 g Powder for solution for injection Intravenous use 1 g/30 ml

Portugal AstraZeneca Produtos Farmacêuticos, Lda. Rua Humberto Madeira, n.o 7, Valejas 2745-663 Barcarena, Portugal Meronem 500 mg Powder for solution for injection Intramuscular use 500 mg/2 ml (not marketed)

Portugal AstraZeneca Produtos Farmacêuticos, Lda. Rua Humberto Madeira, n.o 7, Valejas 2745-663 Barcarena, Portugal Meronem 500 mg Powder for solution infusion Intravenous use 500 mg/20 ml

Portugal AstraZeneca Produtos Farmacêuticos, Lda. Rua Humberto Madeira, n.o 7, Valejas 2745-663 Barcarena, Portugal Meronem 1 g Powder for solution for injection or infusion Intravenous use 1 g/30 ml

Romania AstraZeneca UK Limited 600 Capability Green Luton Bedfordshire LU1 3LU United Kingdom Meronem i.v. 500 mg 500 mg Powder for solution for injection or infusion Intravenous use 500 mg/20 ml

Romania AstraZeneca UK Limited 600 Capability Green Luton Bedfordshire LU1 3LU United Kingdom Meronem i.v. 1 g 1 g Powder for solution for injection or infusion Intravenous use 1 g/30 ml

Slovak Republic AstraZeneca UK Ltd. Silk Road Business Park 1 Macclesfield Cheshire SK10 2NA United Kingdom Meronem 500 mg i.v. 500 mg Powder for solution for injection or infusion Intravenous use 500 mg/20 ml

Slovenia AstraZeneca UK Limited 15 Stanhope Gate London W1K 1LN United Kingdom Meronem 500 mg prasek za raztopino za injiciranje ali infundiranje 500 mg Powder for solution for injection or infusion Intravenous use 50 mg/ml

Slovenia AstraZeneca UK Limited 15 Stanhope Gate London W1K 1LN United Kingdom Meronem 1 g prasek za raztopino za injiciranje ali infundiranje 1 g Powder for solution for injection or infusion Intravenous use 50 mg/ml

Spain AstraZeneca Farmacéutica Spain, S.A. C/ Serrano Galvache 56 Edificio Roble 28033 Madrid Spain Meronem I.V., 500 500 mg Powder for solution for injection or infusion Intravenous use 500 mg/20 ml

Spain AstraZeneca Farmacéutica Spain, S.A. C/ Serrano Galvache 56 Edificio Roble 28033 Madrid Spain Meronem I.V., 1 000 1 g Powder for solution for injection or infusion Intravenous use 1 g/30 ml

Sweden AstraZeneca AB 151 85 Södertälje Sweden Meronem 500 mg Powder for solution for injection or infusion Intravenous use 500 mg/10 ml for injection or variable concentration for infusion

Sweden AstraZeneca AB 151 85 Södertälje Sweden Meronem 1 g Powder for solution for injection or infusion Intravenous use 1 g/20 ml for injection or variable concentration for infusion

United Kingdom AstraZeneca UK Limited 600 Capability Green Luton Bedfordshire LU1 3LU United Kingdom Meronem IV 500 mg 500 mg Powder for solution for injection or infusion Intravenous use 500 mg/20 ml